Estimate selection determines the apparent mortality threshold at 13 mL/kg/h - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Selection of Estimation Influences the Observed Mortality Threshold at 13 mL/kg/h

  • By

  • Shuhao Mei

  • Hailian Yi

  • Yuyin Han

  • Boran Dong

  • Yong Liu

  • Xiaoyang Gong

  • September 15, 2026

Share

Selection of Estimation Influences the Observed Mortality Threshold at 13 mL/kg/h

Background

The association between CRRT dosing and patient outcomes is critical in managing acute kidney injury in critically ill patients. Variability in analytical methods can significantly impact the interpretation of mortality data.

Data Highlights

EstimateHazard Ratio (HR)95% Confidence Interval (CI)
Conventional Analysis1.701.16–2.49
Marginal Structural Analysis1.080.74–1.58
Alternative Estimate0.870.66–1.14

Key Findings

  • Very-low-dose CRRT (<13 mL/kg/h) is associated with increased 90-day mortality (OR, 1.72; 95% CI, 1.31–2.24).
  • Different analytical models yield varying hazard ratios for CRRT dosing, affecting mortality interpretations.
  • The conventional Cox model reported an HR of 1.70, while the marginal structural model indicated an HR of 1.08.
  • Adjustment for time-dependent factors in the marginal structural analysis nullified the baseline association.
  • Selection of estimates for meta-analysis can significantly influence pooled results and their clinical interpretation.

Clinical Implications

Clinicians should be aware of the variability in mortality estimates based on the analytical methods used in studies of CRRT dosing.

Conclusion

The findings underscore the importance of methodological transparency in research on CRRT dosing and its impact on mortality, highlighting the need for consistent reporting practices.

Related Resources & Content

  1. Lumlertgul et al., 2024 -- Selection of Estimation Influences the Observed Mortality Threshold at 13 mL/kg/h
  2. Faria and Libório, 2024 -- Continuous Kidney Replacement Therapy Dosage and Mortality in Critically Ill Patients
  3. Okamoto et al., 2024 -- Low-Dose Continuous Kidney Replacement Therapy and Mortality
  4. Intensive Care Medicine — A predictive model for assessing mortality risk among emergency department patients
  5. American Journal of Epidemiology — Commentary: The Impact of Incomplete Mortality Data on Cumulative Risk Assessments
  6. Intensive Care Medicine — Discrepancies in Mortality Rates Among Septic Shock Trials: A Systematic Review of Population Characteristics and Control Group Outcomes
  7. KDIGO 2026 AKI/AKD Guideline Public Review Draft
  8. Surviving Sepsis Campaign: Critical Care Medicine
  9. Korean Society of Nephrology 2025 evidence-based clinical practice guideline for continuous kidney replacement therapy - PMC
  10. Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients | New England Journal of Medicine
  11. Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury | New England Journal of Medicine
  12. Lower versus standard dose-intensity continuous renal replacement therapy: a systematic review and meta-analysis - PMC
  13. Low-Dose Continuous Kidney Replacement Therapy and Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Cohort Study - PubMed
  14. CONTINUOUS KIDNEY REPLACEMENT THERAPY DOSAGE AND MORTALITY IN CRITICALLY ILL PATIENTS: A RETROSPECTIVE COHORT STUDY USING MARGINAL STRUCTURAL MODEL.

Original Source(s)

Related Content